Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

December 23, 2020
Brenna L. Brady, PhD

,
Matthew Lucci, MPH

,
Kathleen Wilson, MPH

,
Kathleen M. Fox, PhD

,
Jeffrey Wojtynek, PharmD

,
Chelsea Cooper, PharmD

,
Helen Varker, BS

,
Christina Larson Chebili, MA

,
Igoni Dokubo, MD

Evidence-Based Oncology, January 2021, Volume 27, Issue 1

Supplemental materials for article examining the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.